GO:0017070 U6 snRNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0017070 (U6 snRNA binding) is a molecular function defined as binding to a U6 small nuclear RNA (U6 snRNA).
• U6 snRNA is the catalytic core of the spliceosome, and its binding by proteins and snRNAs is essential for pre-mRNA splicing.
• Key U6 snRNA-binding proteins include PRPF8, SNRNP200, LSM2-8, PRP8, and the terminal uridylyltransferase TUT1, which oligouridylates U6 snRNA.
• U6 snRNA is modified by m6A methyltransferase METTL16, and this modification regulates its stability and function.
• Mutations in U4 and U6 snRNA genes cause retinitis pigmentosa, linking U6 snRNA binding to human disease.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of U6 snRNA-binding factors.
Description
U6 snRNA binding (GO:0017070) is a molecular function that describes the selective interaction of a protein or another RNA with U6 small nuclear RNA (U6 snRNA). U6 snRNA is a highly conserved, uridine-rich non-coding RNA that forms the catalytic core of the spliceosome, the macromolecular machine responsible for removing introns from pre-mRNA. The binding of U6 snRNA by specific proteins and by other snRNAs is a prerequisite for spliceosome assembly, activation, and catalysis. Consequently, U6 snRNA binding is central to the regulation of gene expression in eukaryotes. Researchers study this function to understand splicing mechanisms, RNA modification, and the molecular basis of diseases caused by splicing defects. The importance of U6 snRNA binding extends beyond basic splicing: it is also required for minor spliceosome function, U6 snRNA 3' end processing, and quality control of snRNA biogenesis.
U6 snRNA binding At A Glance
| GO ID | GO:0017070 |
|---|---|
| GO term | U6 snRNA binding |
| Ontology | molecular_function |
| Synonym | None |
| Definition | Binding to a U6 small nuclear RNA (U6 snRNA). |
| Major function | Recognition and interaction with U6 snRNA during spliceosome assembly, catalysis, and snRNA processing. |
| Related processes | Pre-mRNA splicing, spliceosome assembly, U6 snRNA modification, U6 snRNA 3' end processing. |
| Key proteins | PRPF8, SNRNP200, LSM2-8, TUT1, METTL16, RBM22. |
| Disease relevance | Retinitis pigmentosa, splicing-related disorders, cancer. |
What Is GO:0017070?
According to the Gene Ontology, GO:0017070 (U6 snRNA binding) is the molecular function of binding to a U6 small nuclear RNA (U6 snRNA). This term encompasses any stable, non-covalent interaction between a protein or another biomolecule and U6 snRNA, including sequence-specific and structural recognition. It does not describe catalytic activity per se, but rather the binding event that positions U6 snRNA for its roles in spliceosome assembly and catalysis.
Why Is U6 snRNA binding Important in Cell Biology?
U6 snRNA binding is essential for pre-mRNA splicing, a fundamental step in eukaryotic gene expression. Without proper binding of U6 snRNA by spliceosomal proteins and its pairing with U2 and U4 snRNAs, introns cannot be removed, leading to defective mRNAs and disease. Moreover, U6 snRNA binding proteins such as TUT1 and METTL16 regulate U6 snRNA stability and modification, adding layers of post-transcriptional control. Mutations in U6 snRNA or its binding partners are linked to retinitis pigmentosa and other splicing-related pathologies. Thus, understanding U6 snRNA binding provides mechanistic insights into splicing and identifies therapeutic targets.
• U6 snRNA binding is required for the catalytic step of pre-mRNA splicing.
• It ensures correct assembly and activation of the spliceosome.
• It regulates U6 snRNA 3' end oligouridylation and stability via TUT1.
• It is modulated by m6A modification of U6 snRNA by METTL16.
• Defects in U6 snRNA binding cause retinitis pigmentosa.
• It is essential for minor spliceosome function involving U12-U6atac snRNA.
• It influences RNA polymerase II transcription of U6 snRNA and its stability.
• It is a target for CRISPR-based functional genomics of splicing factors.
• It has implications for cancer and neurodegenerative diseases linked to splicing dysregulation.
• It provides a model for studying RNA-protein interactions and RNA modification.
What Happens During U6 snRNA binding?
Spliceosome assembly and U6 snRNA incorporation
In simple terms: U6 snRNA is brought into the spliceosome by binding to proteins and other RNAs.
During spliceosome assembly, U6 snRNA is incorporated as part of the U4/U6.U5 tri-snRNP. The binding of U6 snRNA by the LSM2-8 complex and PRPF8 is critical for its stability and function. U6 snRNA then undergoes major structural rearrangements, including the unwinding of U4/U6 duplex, to form the catalytic core with U2 snRNA.
Catalytic activation and U6 snRNA pairing
In simple terms: U6 snRNA pairs with U2 snRNA to form the active site that cuts introns.
After incorporation, U6 snRNA base-pairs with U2 snRNA to form the catalytic center of the spliceosome. This pairing is stabilized by proteins such as PRPF8 and SNRNP200. The binding of U6 snRNA to the intron's 5' splice site and its interaction with magnesium ions enable the two transesterification reactions of splicing.
U6 snRNA modification and 3' end processing
In simple terms: U6 snRNA gets chemical tags and its tail is trimmed to make it functional.
U6 snRNA is post-transcriptionally modified, including m6A methylation by METTL16, which affects its binding to proteins and its stability. The 3' end of U6 snRNA is oligouridylated by TUT1, a U6 snRNA-specific terminal uridylyltransferase, which is important for its maturation and recycling. These modifications influence U6 snRNA binding by spliceosomal proteins.
Spliceosome disassembly and U6 snRNA release
In simple terms: After splicing, the spliceosome falls apart and U6 snRNA is released.
Following catalysis, the spliceosome is disassembled in an ATP-dependent manner. Recent structural studies have revealed how U6 snRNA is released from the post-catalytic spliceosome, involving the helicase SNRNP200 and other factors. This step is crucial for recycling U6 snRNA for subsequent rounds of splicing.
Key Genes Involved in GO:0017070 U6 snRNA binding
The following genes encode proteins or RNAs that directly bind U6 snRNA or are essential for its function in splicing and processing.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRPF8 | Core spliceosomal protein that binds U6 snRNA and stabilizes the catalytic core | Mutations cause retinitis pigmentosa; target for splicing studies |
| SNRNP200 | RNA helicase that unwinds U4/U6 and facilitates U6 snRNA release | Essential for spliceosome disassembly; studied in splicing and disease |
| LSM2 | Component of LSM2-8 complex that binds U6 snRNA 3' end | Required for U6 snRNA stability; knockout affects splicing |
| LSM3 | LSM complex subunit binding U6 snRNA | Model for snRNA-binding studies |
| LSM4 | LSM complex subunit binding U6 snRNA | Involved in U6 snRNA biogenesis |
| LSM5 | LSM complex subunit binding U6 snRNA | Potential target for splicing modulation |
| LSM6 | LSM complex subunit binding U6 snRNA | Studied in snRNP assembly |
| LSM7 | LSM complex subunit binding U6 snRNA | Relevant to RNA stability |
| LSM8 | LSM complex subunit binding U6 snRNA | Key for U6 snRNA 3' end protection |
| TUT1 | U6 snRNA-specific terminal uridylyltransferase that oligouridylates U6 snRNA | Regulates U6 snRNA maturation; structural studies available |
| METTL16 | m6A methyltransferase that modifies U6 snRNA | Links RNA modification to U6 snRNA binding and stability |
| RBM22 | Protein that binds U12-U6atac snRNA complex in minor spliceosome | Studied for minor spliceosome function |
| U6 snRNA (RNU6) | Non-coding RNA that is the substrate for binding | Mutations cause retinitis pigmentosa |
| U4 snRNA (RNU4) | Forms duplex with U6 snRNA; mutations cause disease | Disease modeling and splicing research |
| PRPF6 | Spliceosomal protein that interacts with U6 snRNA | Potential disease gene |
| PRPF3 | U4/U6 snRNP protein | Linked to retinitis pigmentosa |
| PRPF4 | U4/U6 snRNP protein | Involved in U6 snRNA binding |
How Is U6 snRNA binding Regulated?
U6 snRNA binding is regulated at multiple levels. The abundance and modification status of U6 snRNA itself are controlled by transcription by RNA polymerase II (or III in some organisms) and by 3' end processing enzymes such as TUT1. METTL16-mediated m6A modification of U6 snRNA modulates its interaction with binding proteins and affects splicing efficiency. Additionally, the assembly and disassembly of the spliceosome are ATP-dependent and regulated by helicases like SNRNP200, which control the accessibility of U6 snRNA. Cellular stress and metabolic signals can also influence splicing by altering the availability of U6 snRNA-binding proteins.
U6 snRNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| U6 snRNA (RNU6) | Retinitis pigmentosa | Knock-in of patient mutations in cell lines; retinal organoids |
| U4 snRNA (RNU4) | Retinitis pigmentosa | Point mutation knock-in in HEK293 or iPSCs |
| PRPF8 | Retinitis pigmentosa, cancer | Knockout and point mutation in cancer cell lines |
| SNRNP200 | Splicing-related disorders | Knockout in HeLa or HEK293 for splicing assays |
| TUT1 | U6 snRNA processing defects | Overexpression and knockout for oligouridylation studies |
Retinitis pigmentosa and U6 snRNA mutations
De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa, a degenerative retinal disease. These mutations likely disrupt U6 snRNA binding to spliceosomal proteins, leading to defective splicing of genes essential for photoreceptor survival. This establishes U6 snRNA binding as a direct link to human inherited blindness.
Cancer and splicing dysregulation
Alterations in spliceosome components that bind U6 snRNA, such as PRPF8 and SNRNP200, are observed in various cancers. Dysregulated U6 snRNA binding can lead to aberrant splicing of oncogenes and tumor suppressors, contributing to cancer progression. Targeting these interactions is an emerging therapeutic strategy.
Neurodegeneration and splicing defects
Defects in U6 snRNA binding and spliceosome assembly are implicated in neurodegenerative diseases, including amyotrophic lateral sclerosis and spinal muscular atrophy. Mutations in splicing factors that interact with U6 snRNA can cause neuronal dysfunction, highlighting the importance of this molecular function in the nervous system.
From U6 snRNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a U6 snRNA-binding protein affect splicing? | CRISPR knockout in HEK293 or HeLa cells followed by RNA-seq |
| How do disease mutations in U6 snRNA affect binding? | Point mutation knock-in of U6 snRNA variants in cell lines |
| What is the interactome of U6 snRNA? | Knock-in of tagged U6 snRNA or binding proteins for proteomics |
| Can overexpression of TUT1 alter U6 snRNA stability? | Overexpression of TUT1 in mammalian cells |
| What is the role of METTL16 in U6 snRNA modification? | Knockout and point mutation of METTL16 in cell lines |
| How does SNRNP200 regulate U6 snRNA release? | Knockout or ATPase-dead point mutation of SNRNP200 |
How to Study the U6 snRNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA immunoprecipitation (RIP) | Binding of proteins to U6 snRNA | Identify U6 snRNA-binding proteins |
| CLIP-seq | Protein-RNA interaction sites at nucleotide resolution | Map U6 snRNA binding sites |
| Cryo-EM | 3D structure of spliceosome complexes | Visualize U6 snRNA interactions |
| X-ray crystallography | Atomic structure of U6 snRNA-binding proteins | Study TUT1 and METTL16 |
| RNA-seq | Global splicing changes | Assess impact of U6 snRNA binding loss |
| Minigene splicing assay | Splicing of a specific reporter | Test U6 snRNA mutations |
| CRISPR knockout screen | Genes required for splicing | Discover novel U6 snRNA regulators |
| m6A-seq | m6A modification of U6 snRNA | Study METTL16 function |
RNA immunoprecipitation and crosslinking
RNA immunoprecipitation (RIP) and CLIP-based methods can identify proteins that bind U6 snRNA in vivo. These techniques use antibodies against candidate proteins or tagged proteins, followed by sequencing of bound RNAs. They are essential for mapping U6 snRNA binding sites and dynamics.
Structural biology (cryo-EM and crystallography)
Cryo-electron microscopy and X-ray crystallography have revealed high-resolution structures of the spliceosome and U6 snRNA-binding proteins, such as TUT1 and METTL16. These methods provide mechanistic insights into how U6 snRNA is recognized and modified.
RNA sequencing and splicing assays
RNA-seq and targeted splicing assays measure the impact of U6 snRNA binding perturbations on pre-mRNA splicing. Knockout or knockdown of U6 snRNA-binding factors followed by RNA-seq reveals global splicing changes. Minigene reporters can test specific splicing events.
CRISPR screens and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for U6 snRNA binding and splicing. These screens use splicing reporters or cell viability readouts to uncover novel regulators. They are powerful for discovering disease-relevant pathways.
How CRISPR Can Be Used to Study GO:0017070 U6 snRNA binding
Knockout
CRISPR knockout of genes encoding U6 snRNA-binding proteins (e.g., PRPF8, LSM2-8, TUT1) allows researchers to assess their essentiality for splicing and cell viability. Knockout cell lines can be used for RNA-seq and proteomics to identify downstream effects.
Point Mutation
Point mutations can be introduced into U6 snRNA or its binding proteins to mimic disease-associated variants, such as those causing retinitis pigmentosa. These models help dissect the molecular consequences of specific amino acid or nucleotide changes on U6 snRNA binding affinity and splicing activity.
Knock-in
Knock-in of tagged U6 snRNA or tagged binding proteins (e.g., GFP or HA tags) enables affinity purification and imaging of U6 snRNA-protein complexes in live cells. This approach is valuable for studying dynamic interactions during spliceosome assembly.
Overexpression
Overexpression of U6 snRNA-binding proteins such as TUT1 or METTL16 can reveal gain-of-function phenotypes and their impact on U6 snRNA modification and stability. Overexpression models are useful for structural and biochemical studies.
How EDITGENE Supports U6 snRNA binding Research
Researchers studying U6 snRNA binding-related genes often need to determine whether a candidate gene is causally involved in splicing regulation or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for functional validation.
Contact EDITGENE today to design your custom CRISPR model for U6 snRNA binding research.
Frequently Asked Questions About U6 snRNA binding
What is GO:0017070?
GO:0017070 is the Gene Ontology molecular function term for U6 snRNA binding, defined as binding to a U6 small nuclear RNA (U6 snRNA).
What genes are involved in U6 snRNA binding?
Key genes include PRPF8, SNRNP200, LSM2-8, TUT1, METTL16, and RBM22, as well as the U6 snRNA gene itself (RNU6).
What is the function of U6 snRNA binding in splicing?
U6 snRNA binding is essential for spliceosome assembly, catalytic activation, and disassembly, enabling pre-mRNA splicing.
How is U6 snRNA binding regulated?
It is regulated by U6 snRNA modifications (e.g., m6A by METTL16), 3' end oligouridylation by TUT1, and ATP-dependent helicases like SNRNP200.
What diseases are associated with U6 snRNA binding?
Mutations in U4 and U6 snRNA genes cause retinitis pigmentosa, and dysregulated U6 snRNA binding is implicated in cancer and neurodegeneration.
How can I study U6 snRNA binding using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of U6 snRNA-binding proteins and their roles in splicing.
What methods are used to detect U6 snRNA binding?
RNA immunoprecipitation, CLIP-seq, cryo-EM, and crystallography are commonly used to study U6 snRNA-protein interactions.
Is U6 snRNA binding conserved across species?
Yes, U6 snRNA and its binding partners are highly conserved from yeast to humans, making model organisms valuable for research.
What is the role of TUT1 in U6 snRNA binding?
TUT1 is a terminal uridylyltransferase that oligouridylates U6 snRNA, regulating its maturation and stability.
How does METTL16 affect U6 snRNA?
METTL16 methylates U6 snRNA at m6A, influencing its binding to proteins and its stability.
Conclusion
U6 snRNA binding (GO:0017070) is a fundamental molecular function that underpins pre-mRNA splicing and gene expression. Its dysregulation leads to human diseases such as retinitis pigmentosa and cancer. Advances in structural biology and CRISPR technologies continue to illuminate the mechanisms and regulatory networks of U6 snRNA binding. EDITGENE provides the tools to model these interactions and accelerate therapeutic discovery.
References
- 1. Wilkinson ME et al.. 2020. RNA Splicing by the Spliceosome.. Annu Rev Biochem 89:359-388 PMID: 31794245
- 2. Vorländer MK et al.. 2024. Mechanism for the initiation of spliceosome disassembly.. Nature 632(8024):443-450 PMID: 38925148
- 3. Ju J et al.. 2025. Structures and mechanisms of U6 snRNA m(6)A modification by METTL16.. Nat Commun 16(1):7708 PMID: 40841561
- 4. Quinodoz M et al.. 2026. De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa.. Nat Genet 58(1):169-179 PMID: 41513982
- 5. Yamashita S et al.. 2023. Mechanism of U6 snRNA oligouridylation by human TUT1.. Nat Commun 14(1):4686 PMID: 37563152
- 6. Ciavarella J et al.. 2020. Topology of the U12-U6(atac) snRNA Complex of the Minor Spliceosome and Binding by NTC-Related Protein RBM22.. ACS Omega 5(37):23549-23558 PMID: 32984674
- 7. Yamashita S et al.. 2017. Crystal structures of U6 snRNA-specific terminal uridylyltransferase.. Nat Commun 8:15788 PMID: 28589955
- 8. Lipinski KA et al.. 2022. Yeast U6 snRNA made by RNA polymerase II is less stable but functional.. RNA 28(12):1606-1620 PMID: 36195346
